登革热临床试验核心结局测量集:国际德尔菲共识研究(DEN-CORE)
该国际共识研究遵循COMET与COS-STAD指南,分两阶段制定登革热临床试验核心结局测量集(COMS)。重症监护建议使用现有ICU专用COS。研究为9个临床医生报告结局制定统一定义,旨在协调结局选择与测量。
要点
- 住院登革热试验应采用含7个结局的COMS。
- 早期登革热COMS在住院集基础上增加4个结局。
- ICU试验推荐使用现有ICU专用核心结局集。
核心结论
- DEN-CORE COMS为登革热试验提供共识框架,协调结局选择与测量,提升可比性并支持政策与临床决策。
研究设计与样本
- 遵循COMET与COS-STAD指南的两阶段国际共识研究。
- 第一阶段通过系统文献综述、定性访谈、管理组与指导委员会审核、两轮改良德尔菲调查及结构化在线共识会议形成COS。
- 第二阶段通过靶向结局测量工具综述与混合国际共识研讨会最终确定COMS。
主要发现
- 住院登革热商定的COMS包含7个结局。
- 早期登革热COS包含上述7个结局另加4个结局。
- 为9个临床医生报告结局制定了统一定义。
关键数值与推荐
- 住院登革热试验使用含7个结局的COMS。
- 重症监护试验推荐使用现有ICU专用COS。
临床怎么用
- 登革热临床试验应参照DEN-CORE COMS选择与测量结局。
- 早期与住院阶段试验采用对应的COS以保证可比性。
- ICU登革热试验沿用现有ICU专用核心结局集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dengue, caused by any one of four distinct virus serotypes, is the most rapidly spreading mosquito-borne viral disease worldwide. It is a primary arboviral infection with increasing global incidence, driven by climate change, urbanisation, and the expanding range of Aedes mosquito vectors. Despite growing research interest, outcome and measurement instrument heterogeneity in dengue clinical trials remains high, limiting comparability and evidence synthesis. This project aimed to develop a globally relevant Core Outcome Measurement Set (COMS) for use in dengue clinical trials through international consensus. This consensus study followed core outcome measures in effectiveness trials and Core Outcome Set-Standards for Development (COS-STAD) guidelines and was conducted in two phases. Phase 1 focused on developing a Core Outcome Set (COS) through four steps: (1) a systematic literature review; (2) qualitative interviews with people with lived experience of dengue; (3) review by the management group and steering committee; (4) a two-round modified Delphi survey and structured online consensus meetings to finalise the COS for hospitalised and early stages of dengue disease. Input from critical care experts informed recommendations for the intensive care unit (ICU) and high dependency unit COS. Phase 2 consisted of a further two steps: (1) targeted review of outcome measurement instruments; and (2) a hybrid international consensus workshop to finalise the COMS. The agreed COMS for hospitalised dengue included seven outcomes; the early stage dengue COS included these outcomes plus four more. For critical care trials, use of existing ICU-specific COS was recommended. Unified definitions were developed for nine clinician-reported outcomes. The DEN-CORE COMS provides a consensus-based framework for harmonising outcome selection and measurement in dengue trials, improving comparability and supporting policy and clinical decision making.
引用
- Yacoub S, Demidova A, Chan XHS, et al. Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE). Lancet Infect Dis. 2025. PMID: 41072450. doi:10.1016/S1473-3099(25)00500-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。